☰

Eugenie Mutez - Publications

Affiliations: 
INSERM, Lille, France 
Tree Info Grants Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Naaldijk Y, Fernández B, Fasiczka R, Fdez E, Leghay C, Croitoru I, Kwok JB, Boulesnane Y, Vizeneux A, Mutez E, Calvez C, Destée A, Taymans JM, Aragon AV, Yarza AB, et al. A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells. Npj Parkinson's Disease. 10: 12. PMID 38191886 DOI: 10.1038/s41531-023-00624-8  0.699
2023 Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, Amos C, McKay JD, Hung RJ, Karimi M, Bacq-Daian D, Boland-Augé A, Olaso R, Deleuze JF, Lesueur F, ... ... Mutez E, et al. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36788297 DOI: 10.1002/mds.29337  0.663
2023 Taymans JM, Mutez E, Sibran W, Vandewynckel L, Deldycke C, Bleuse S, Marchand A, Sarchione A, Leghay C, Kreisler A, Simonin C, Koprich J, Baille G, Defebvre L, Dujardin K, et al. Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkers. Npj Parkinson's Disease. 9: 21. PMID 36750568 DOI: 10.1038/s41531-023-00445-9  0.662
2022 Grover S, Kumar Sreelatha AA, Pihlstrom L, Domenighetti C, Schulte C, Sugier PE, Radivojkov-Blagojevic M, Lichtner P, Mohamed O, Portugal B, Landoulsi Z, May P, Bobbili D, Edsall C, Bartusch F, ... ... Mutez E, et al. Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium. Neurology. 99: e698-e710. PMID 35970579 DOI: 10.1212/WNL.0000000000200699  0.681
2022 Domenighetti C, Douillard V, Sugier PE, Sreelatha AAK, Schulte C, Grover S, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Gourraud PA, Mellick GD, ... ... Mutez E, et al. The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35810454 DOI: 10.1002/mds.29133  0.628
2022 Coku I, Mutez E, Eddarkaoui S, Carrier S, Marchand A, Deldycke C, Goveas L, Baille G, Tir M, Magnez R, Thuru X, Vermeersch G, Vandenberghe W, Buée L, Defebvre L, et al. Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35708213 DOI: 10.1002/mds.29124  0.635
2022 Grover S, Ashwin AKS, Pihlstrom L, Domenighetti C, Schulte C, Sugier PE, Radivojkov-Blagojevic M, Lichtner P, Mohamed O, Portugal B, Landoulsi Z, May P, Bobbili D, Edsall C, Bartusch F, ... ... Mutez E, et al. Genome-wide Association and Meta-analysis of Age-at-Onset in Parkinson Disease: Evidence From COURAGE-PD Consortium. Neurology. PMID 35618440 DOI: 10.1212/WNL.0000000000200699  0.759
2022 Grover S, Ashwin AKS, Pihlstrom L, Domenighetti C, Schulte C, Sugier PE, Radivojkov-Blagojevic M, Lichtner P, Mohamed O, Portugal B, Landoulsi Z, May P, Bobbili D, Edsall C, Bartusch F, ... ... Mutez E, et al. Genome-wide Association and Meta-analysis of Age-at-Onset in Parkinson Disease: Evidence From COURAGE-PD Consortium. Neurology. PMID 35618440 DOI: 10.1212/WNL.0000000000200699  0.759
2022 Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, ... ... Mutez E, et al. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34997937 DOI: 10.1002/mds.28902  0.675
2021 Domenighetti C, Sugier PE, Sreelatha AAK, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, ... ... Mutez E, et al. Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease. Journal of Parkinson's Disease. PMID 34633332 DOI: 10.3233/JPD-212851  0.633
2021 Drouyer M, Bolliger MF, Lobbestael E, Van den Haute C, Emanuele M, Lefebvre R, Sibran W, De Wit T, Leghay C, Mutez E, Dzamko N, Halliday GM, Murayama S, Martoriati A, Cailliau K, et al. Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation. Neurobiology of Disease. 105426. PMID 34144124 DOI: 10.1016/j.nbd.2021.105426  0.638
2021 Goveas L, Mutez E, Chartier-Harlin MC, Taymans JM. Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells. Cells. 10. PMID 33922322 DOI: 10.3390/cells10050981  0.634
2020 Mangone G, Bekadar S, Cormier-Dequaire F, Tahiri K, Welaratne A, Czernecki V, Pineau F, Karachi C, Castrioto A, Durif F, Tranchant C, Devos D, Thobois S, Meissner WG, Navarro MS, ... ... Mutez E, et al. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations. Parkinsonism & Related Disorders. 76: 56-62. PMID 32866938 DOI: 10.1016/J.Parkreldis.2020.04.002  0.513
2020 Keo A, Mahfouz A, Ingrassia AMT, Meneboo JP, Villenet C, Mutez E, Comptdaer T, Lelieveldt BPF, Figeac M, Chartier-Harlin MC, van de Berg WDJ, van Hilten JJ, Reinders MJT. Transcriptomic signatures of brain regional vulnerability to Parkinson's disease. Communications Biology. 3: 101. PMID 32139796 DOI: 10.1038/s42003-020-0804-9  0.619
2020 Blaise A, Baille G, Carriere N, Devos D, Dujardin K, Grolez G, Kreisler A, Kyheng M, moreau c, Mutez E, Seguy D, Defebvre L. Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study. Revue Neurologique. 176: 268-276. PMID 31668287 DOI: 10.1016/J.Neurol.2019.07.024  0.398
2019 Fernández B, Lara Ordóñez AJ, Fdez E, Mutez E, Comptdaer T, Leghay C, Kreisler A, Simonin C, Vandewynckel L, Defebvre L, Destée A, Bleuse S, Taymans JM, Chartier-Harlin MC, Hilfiker S. Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients. The Biochemical Journal. PMID 31527116 DOI: 10.1042/Bcj20190315  0.677
2018 Cuvelier E, Méquinion M, Leghay C, Sibran W, Stievenard A, Sarchione A, Bonte MA, Vanbesien-Mailliot C, Viltart O, Saitoski K, Caron E, Labarthe A, Comptdaer T, Semaille P, Carrié H, ... Mutez E, et al. Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice. Frontiers in Molecular Neuroscience. 11: 321. PMID 30333721 DOI: 10.3389/Fnmol.2018.00321  0.567
2018 Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, et al. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology. PMID 29752303 DOI: 10.1212/Wnl.0000000000005660  0.469
2017 Dufournet B, Nguyen K, Charles P, Grabli D, Jacquette A, Borg M, Danaila T, Mutez E, Drapier S, Colin O, Eusebio A, Philip N, Azulay JP. Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment. Revue Neurologique. PMID 28461026 DOI: 10.1016/J.Neurol.2017.03.021  0.464
2017 Taymans JM, Mutez E, Drouyer M, Sibran W, Chartier-Harlin MC. LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker? Biochemical Society Transactions. 45: 207-212. PMID 28202674 DOI: 10.1042/Bst20160334  0.697
2016 Nkiliza A, Mutez E, Simonin C, Leprêtre F, Duflot A, Figeac M, Villenet C, Semaille P, Comptdaer T, Genet A, Sablonnière B, Devos D, Defebvre L, Destée A, Chartier-Harlin MC. RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease. Neurobiology of Disease. 96: 312-322. PMID 27663142 DOI: 10.1016/J.Nbd.2016.09.014  0.692
2016 Marelli C, Guissart C, Hubsch C, Renaud M, Villemin JP, Larrieu L, Charles P, Ayrignac X, Sacconi S, Collignon P, Cuntz-Shadfar D, Perrin L, Benarrosh A, Degardin A, Lagha-Boukbiza O, ... Mutez E, et al. Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited Ataxias. Human Mutation. PMID 27528516 DOI: 10.1002/Humu.23063  0.305
2014 Rambour M, Moreau C, Salleron J, Devos D, Kreisler A, Mutez E, Simonin C, Annic A, Dujardin K, Destée A, Defebvre L. [Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients]. Revue Neurologique. 170: 205-15. PMID 24594365 DOI: 10.1016/J.Neurol.2013.10.012  0.398
2014 Mutez E, Nkiliza A, Belarbi K, de Broucker A, Vanbesien-Mailliot C, Bleuse S, Duflot A, Comptdaer T, Semaille P, Blervaque R, Hot D, Leprêtre F, Figeac M, Destée A, Chartier-Harlin MC. Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease. Neurobiology of Disease. 63: 165-70. PMID 24269915 DOI: 10.1016/J.Nbd.2013.11.007  0.728
2014 Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, ... ... Mutez E, et al. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiology of Aging. 35: 266.e5-14. PMID 23962496 DOI: 10.1016/J.Neurobiolaging.2013.07.013  0.616
2013 Heckman MG, Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, ... ... Mutez E, et al. Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1740-4. PMID 23913756 DOI: 10.1002/Mds.25600  0.679
2012 Mutez E, Duflot A, Figeac M, Hot D, Blervaque R, Vanbesien-Mailliot C, Semaille P, Simonin C, Kreisler A, Destée A, Chartier-Harlin M-. 3.262 Deregulation Of Gene Expression In Peripheral Blood Mononuclear Cells At Different Stages Of The Parkinson'S Disease Parkinsonism & Related Disorders. 18. DOI: 10.1016/S1353-8020(11)70932-4  0.64
2012 Vanbesien-Mailliot C, Mutez E, Kreisler A, Simonin C, Duflot A, Semaille P, Peckeu S, Destée A, Chartier-Harlin M-. 3.112 Transcriptome Profiling Of Blood Mononuclear Cells From Rats Exposed To Cumulative Low Doses Of The Parkinson'S Disease-Linked Pesticide Rotenone Parkinsonism & Related Disorders. 18. DOI: 10.1016/S1353-8020(11)70830-6  0.632
2012 Simonin C, Mutez E, Sablonnière B, Duflot A, Figeac M, Lepretre F, Defebvre L, Kreisler A, Vanbesien-Mailliot C, Devos D, Frigard B, Destée A, Chartier-Harlin M-. 3.074 Transcriptome Profiling Of Blood Mononuclear Cells From Sca2 Patients According To Cerebellar Or Parkinsonian Phenotypes Parkinsonism & Related Disorders. 18. DOI: 10.1016/S1353-8020(11)70810-0  0.585
2012 Destée A, Mutez E, Rhun EL, Leprêtre F, Semaille P, Duflot A, Vanbesien-Maillot C, Kreisler A, Simonin C, Comptdaer T, Broucker Ad, Dachsel J, Farrer M-, Chartier-Harlin M-. Mutations du gène EIF4G 1 (Eukaryotic translation initiation factor 4-gamma) et maladie de Parkinson Revue Neurologique. 168. DOI: 10.1016/S0035-3787(12)70026-7  0.607
2011 Chartier-Harlin MC, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Leprêtre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. American Journal of Human Genetics. 89: 398-406. PMID 21907011 DOI: 10.1016/J.Ajhg.2011.08.009  0.607
2011 Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, ... ... Mutez E, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. The Lancet. Neurology. 10: 898-908. PMID 21885347 DOI: 10.1016/S1474-4422(11)70175-2  0.721
2011 Mutez E, Leprêtre F, Le Rhun E, Larvor L, Duflot A, Mouroux V, Kerckaert JP, Figeac M, Dujardin K, Destée A, Chartier-Harlin MC. SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes. Human Mutation. 32: E2079-90. PMID 21412942 DOI: 10.1002/Humu.21459  0.668
2011 Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destée A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, ... ... Mutez E, et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Annals of Neurology. 69: 778-92. PMID 21391235 DOI: 10.1002/Ana.22321  0.7
2011 Mutez E, Larvor L, Leprêtre F, Mouroux V, Hamalek D, Kerckaert JP, Pérez-Tur J, Waucquier N, Vanbesien-Mailliot C, Duflot A, Devos D, Defebvre L, Kreisler A, Frigard B, Destée A, et al. Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Neurobiology of Aging. 32: 1839-48. PMID 20096956 DOI: 10.1016/J.Neurobiolaging.2009.10.016  0.71
2010 Mutez E, Larvor L, Leprêtre F, Mouroux V, Hamalek D, Kerckaert J, Pérez-Tur J, Waucquier N, Vanbesien-Mailliot C, Duflot A, Devos D, Defebvre L, Kreisler A, Frigard B, Destée A, et al. Étude transcriptomique de cellules mononucléées sanguines de patients parkinsoniens porteurs de la mutation G2019S de LRRK2 Revue Neurologique. 166: S35-S37. DOI: 10.1016/S0035-3787(10)70016-3  0.617
2009 Mutez E, Duhamel A, Defebvre L, Bordet R, Destée A, Kreisler A. Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease. Pharmacological Research. 60: 41-5. PMID 19427584 DOI: 10.1016/J.Phrs.2009.03.010  0.51
2009 Chartier-Harlin M, Dachsel J, Hulihan M, Kachergus J, Lepretre F, Le Rhun E, Mutez E, Lincoln S, Ross O, Vilariño-Güell C, Yanagiya A, Sonenberg N, Lockhart P, Wszolek Z, Aasly J, et al. P2.206 EIF4G1 mutations in familial parkinsonism Parkinsonism & Related Disorders. 15: S145-S146. DOI: 10.1016/S1353-8020(09)70557-7  0.609
2007 Vanbesien-Mailliot C, Mutez E, Mouroux V, Destee A, Chartier-Harlin M-. 2.402 Low-dose pesticide exposure and early stages of Parkinsonism in a rat model Parkinsonism & Related Disorders. 13. DOI: 10.1016/S1353-8020(08)70722-3  0.565
2007 Mutez E, Mouroux V, Lepetre F, Larvor L, Vanbesien-Mailliot C, Kerckaert JP, Defebvre L, Destee A, Chartier-Harlin M-. 2.105 Transcriptome profiling in peripheral blood cells of LRRK2 G2019S mutation patients Parkinsonism & Related Disorders. 13. DOI: 10.1016/S1353-8020(08)70597-2  0.599
Show low-probability matches.